The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Frameworks for improving comprehensive biomarker testing in NSCLC: A multi-stakeholder consensus.
 
Maureen Zakowski
Consulting or Advisory Role - Genentech
Travel, Accommodations, Expenses - Genentech
 
Juliana Dierks
Consulting or Advisory Role - Various (Inst)
Travel, Accommodations, Expenses - Various in my role as consultant (Inst)
 
David Cobden
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
Other Relationship - Genentech
 
Sarika Ogale
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
 
Zachary Goodman
Employment - Cigna/Evernorth Health
 
Angela Inneh
Employment - The Cigna Group
 
Narjust Florez
Employment - Dana Farber Cancer Hospital
Leadership - IASLC
Consulting or Advisory Role - AstraZeneca; Catalyst Pharmaceuticals; Daiichi Sankyo/Astra Zeneca; Genentech; Janssen; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Merck; Mirati Therapeutics; Novocure; Nuvalent, Inc.; Nuvation Bio; Pfizer; Regeneron
Research Funding - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo/Astra Zeneca; Genentech
Other Relationship - Clinical Care Options; CME Outfitters; IDEOlogy Health; Medscape; OncLive/MJH Life Sciences; PER; Precisca
 
Justin Gainor
Employment - Alkeus Pharmaceuticals (I); Ironwood Pharmaceuticals (I)
Leadership - AI Proteins, Inc
Stock and Other Ownership Interests - AI Proteins, Inc; Ironwood Pharmaceuticals (I)
Honoraria - BeiGene; Merck; Novartis; Pfizer; Takeda
Consulting or Advisory Role - Arcus Biosciences; Array BioPharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Ellipses Pharma; EMD Serono; Genentech; Gilead Sciences; InterVenn Biosciences; ITeos Therapeutics; Lilly; Mariana Oncology; Merck; Merus; Mirati Therapeutics; Moderna Therapeutics; Novartis; Nuvalent, Inc.; Pfizer; Revolution Medicines; Sanofi; Silverback Therapeutics; Takeda; Tempus
Research Funding - Adaptimmune (Inst); Alexo Therapeutics (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Genentech; Jounce Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis; Novartis (Inst); Palleon Pharmaceuticals (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Brendan Heiden
Consulting or Advisory Role - Genentech/Roche
Research Funding - AstraZeneca (Inst)
 
Richard Huang
Employment - Roche/Foundation Medicine
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Patent on IHC; provisional patent on biomarkers and biomarker methodology.
 
Edward Kadel
Employment - Genentech/Roche
Stock and Other Ownership Interests - 89Bio; Alphabet; Amazon; Annovis; Apple; Genentech/Roche; Inspire Medical Systems; Lilly; Merck; SPDR SER TR S&P BIOTECH (XBI); Teladoc; Tempus
Patents, Royalties, Other Intellectual Property - PD-LI PROMOTER METHYLATION IN CANCER United States Patent Kadel et al. Patent No.: US 11,254,987 B2 Date of Patent: Feb. 22, 2022
Travel, Accommodations, Expenses - Genentech/Roche
 
Timothy Larson
Consulting or Advisory Role - Genentech
 
Jesse Sussell
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Bo Wang
Stock and Other Ownership Interests - Roche/Genentech (I)
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; Daiichi Sankyo/Astra Zeneca; EMD Serono; Roche/Genentech
Speakers' Bureau - EMD Serono
Research Funding - Boehringer Ingelheim (Inst); Puma Biotechnology (Inst); Summit Therapeutics (Inst)
 
Jun Zhang
Consulting or Advisory Role - Daiichi Sankyo/Lilly; Genentech; Johnson & Johnson/Janssen; Lilly
 
Fawzi Abu Rous
Honoraria - Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bayer; BMS GmbH & Co. KG; Boehringer Ingelheim; Daiichi Sankyo/Astra Zeneca; Johnson & Johnson/Janssen; Merus; Pfizer; Rigel; Roche/Genentech; SERVIER
 
Kavitha Beedupalli
Consulting or Advisory Role - Genentech/Roche
 
Wade Iams
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb/Pfizer; Catalyst Pharmaceuticals; Daichii Sankyo; Elevation Oncology; EMD Serono; Genentech; Gilead Sciences; Guardant Health; Jazz Pharmaceuticals; Johnson and Johnson; Merus; Novocure; Sanofi; Takeda; Tempus
Speakers' Bureau - Amgen; Jazz Pharmaceuticals; Novocure
 
Jennifer Carlisle
Employment - Piedmont Healthcare (I)
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Catalyst Pharmaceuticals; Genentech/Roche; Gilead Sciences; Guardant Health; ImmunityBio; Lilly; Novocure
Research Funding - amgen (Inst); Astellas Pharma (Inst); Black Diamond Therapeutics (Inst); Clinigen Group (Inst); Daiichi Sankyo RD Novare (Inst); Genentech (Inst); ImmunityBio (Inst); Pfizer (Inst); Pyxis (Inst); Shenzhen Chipscreen Biosciences (Inst)
Travel, Accommodations, Expenses - IASLC
 
Emily Cassidy
Consulting or Advisory Role - Genentech; Intuitive Surgical; Intuitive Surgical; Johnson & Johnson/MedTech; Zimmer BioMet